ASH 2017 – Dr. Stamatopoulos on Stereotypic Immunoglobulins in CLL (chronic lymphocytic leukemia) Dr. Kostas Stamatopoulos has done important basic CLL research, set necessary lab standards and been a strong patient advocate from... Details
ASH 2017: Dr. Jennifer Brown on Bleeding Problems with Ibrutinib in CLL (chronic lymphocytic leukemia) At ASH 2017, Dr. Jennifer Brown, the Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber... Details
ASH 2017: Dr. Dearden on the Progress and Remaining Unmet Needs in CLL (chronic lymphocytic leukemia) At ASH (American Society of Hematology Annual Meeting) in Dec. 2017 in Atlanta, Georgia, I re-interviewed one of the nicest... Details
ASH 2017: Dr. Tam on the Prognostic Value of IVGH mutation status in CLL (chronic lymphocytic leukemia) Dr. Constantine Tam of Peter MacCallum Cancer Center, Melbourne, Australia has contributed important research for chronic lymphocytic leukemia patients while... Details
ASH 2017: Dr. Matthew Davids on Umbralisib (TGR-1202) for chronic lymphocytic leukemia (CLL) At ASH 2017, I interviewed Dr. Matthew Davids on a new PI3K∆ inhibitor, umbralisib (formerly TGR-1202) for treating CLL. We know... Details
ASH 2017: Dr. Jennifer Brown Discusses the Association Between Idelalisib and Liver Inflammation in CLL At the 2017 ASH Annual Meeting, Dr. Brian Koffman interviewed Dr. Jennifer Brown from Dana Farber Cancer Institute at Harvard... Details
ASH 2017: Dr. Follows Discusses the MURANO Trial (Venetoclax and Rituximab) in Chronic Lymphocytic Leukemia (CLL) At the 2017 ASH Annual Meeting in Atlanta, GA, Dr. Brian Koffman interviewed Dr. George Follows from the Cambridge University... Details
ASH 2017: Dr. Choi Discusses the Potential of Non-Chemotherapy Regimens for the Treatment of Chronic Lymphocytic Leukemia (CLL) At the 2017 ASH Annual Meeting in Atlanta, GA, Dr. Brian Koffman interviewed Dr. Michael Choi from the University of... Details
ASH 2017: Dr. Mato on PET Scans Identifying Richter’s Transformation in CLL (chronic lymphocytic leukemia) By Brian Koffman, MD and Anthony Mato, MD As we are getting better at controlling CLL and living longer, there... Details
ASH 2017: Dr. Con Tam on BGB-3111 or Zanubrutinib for Chronic Lymphocytic Leukemia (CLL) Dr. Constantine Tam from Peter McCallum in Melbourne Australia has led pioneering research on important new drugs to treat chronic... Details
